TGM2 and cancer: Our current findings that stable expression of TG2 promotes drug resistance and invasiveness in normal and transformed mammary epithelial cells by inducing EMT suggest that TG2 serves as a converging point in conferring drug resistance and metastatic phenotype in cancer cells.